Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint

INTRODUCTION: Biomarkers predictive of response to mechanistic target of rapamycin (mTOR) inhibitor, everolimus, in endocrine receptor (ER)-positive metastatic breast cancer (MBC) are a work in progress. We evaluated the feasibility of directly measuring mTOR activity and phosphatase and tensin homo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajpai, Jyoti, Ramaswamy, Anant, Chandrasekharan, Arun, Mishra, Surya, Shet, Tanuja, Gupta, Sudeep, Badwe, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
ORIGINAL ARTICLE: Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615875/
https://www.ncbi.nlm.nih.gov/pubmed/28975114
http://dx.doi.org/10.4103/sajc.sajc_113_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615875/
https://www.ncbi.nlm.nih.gov/pubmed/28975114
http://dx.doi.org/10.4103/sajc.sajc_113_17

Ejemplares similares